Skip to content

Clinical trials

Completed Phase 1/2 RNA Virus Infections trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: RNA Virus Infections Phase: Phase 1/2 Status: Completed Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20121
20131
20171
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BioNTech SE1
Biolex Therapeutics, Inc.1
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation1
Medicago1
SPP Pharmaclon Ltd.1
University of Aarhus1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
RNA Virus Infections6
Virus Diseases4
HIV Infections2
Lentivirus Infections2
Respiratory Tract Infections2
Acquired Immunodeficiency Syndrome1
COVID-191
Digestive System Diseases1
Filoviridae Infections1
Flaviviridae Infections1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.